58 results
8-K
EX-10.1
AVGR
Avinger, Inc.
17 Jun 24
Avinger Announces Pricing of up to $24 Million Public Offering
6:03pm
of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval
8-K
EX-10.1
AVGR
Avinger, Inc.
7 Mar 24
Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge
6:30am
to process, prepare, make and Test the raw materials used in the production of the Product and to Test the Product prior to release packaging
8-K
EX-10.2
35wimus9ukq0jio8cr
8 Aug 22
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-10.1
lvwdmgxwkxdh9v7ee
8 Aug 22
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-1.1
8aehyi81ulrox8er
20 May 22
Entry into a Material Definitive Agreement
4:28pm
DEFA14A
EX-10.1
j53o0w4 ofn
12 Jan 22
Additional proxy soliciting materials
4:46pm
8-K
EX-10.1
qw7ca1utq424dy5btyhk
12 Jan 22
Avinger Announces $7.6 Million Registered Direct Offering
4:46pm
8-K
EX-1.1
34dtlw5 7qb51iqq5ih
1 Feb 21
Avinger Announces $14.4 Million Bought Deal Offering of Common Stock
4:18pm
8-K
EX-1.1
j5fmq9yi7eqz
21 Aug 20
Avinger Prices $5.2 Million
5:26pm
8-K
EX-1.1
jkzo5lliuik5mmk
4 Aug 20
Avinger Prices $6 Million
4:17pm
8-K
EX-1.1
td9xgcvrv 7wgxo9kznk
25 Jun 20
Avinger Prices $5.4 Million
9:25am
8-K
EX-1.1
8kjuh7 jh
29 Apr 20
Avinger Prices $3.15 Million
8:30am